We are live on ! Find out more
LAB icon

Standard BioTools
LAB

103 hedge funds and large institutions have $163M invested in Standard BioTools in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more call options, than puts

Call options by funds: $52K | Put options by funds: $30K

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

31% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 32

4% more funds holding

Funds holding: 99 → 103 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.95% less ownership

Funds ownership: 92% → 91.05% (-0.95%)

27% less capital invested

Capital invested by funds: $223M → $163M (-$59.8M)

Holders
103
Holders Change
+4
Holders Change %
+4.04%
% of All Funds
2.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
42
Reduced
32
Closed
12
Calls
$52K
Puts
$30K
Net Calls
+$22K
Net Calls Change
+$102K

Top Buyers

1
Russell Investments Group
Russell Investments Group
United Kingdom
+$4.64M
2
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking
Japan
+$3.59M
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.26M
4
PCMI
Paradigm Capital Management Inc
New York
+$2.66M
5
Millennium Management
Millennium Management
New York
+$2.48M

Top Sellers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.9M
2
PVI
Pura Vida Investments
New York
-$3.8M
3
ECM
Endurant Capital Management
California
-$2.64M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.55M
5
EIP
Easterly Investment Partners
Massachusetts
-$2.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
26
Panagora Asset Management
Massachusetts
$1.06M -$1.15M -351,419 -46%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$961K -$1.72M -522,695 -58%
SAM
28
Silverback Asset Management
North Carolina
$951K +$709K +215,771 +136%
Goldman Sachs
29
Goldman Sachs
New York
$895K +$409K +124,451 +55%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$821K +$239K +72,756 +29%
PCM
31
Perkins Capital Management
Minnesota
$646K +$101K +30,684 +14%
AQR Capital Management
32
AQR Capital Management
Connecticut
$629K +$190K +57,845 +30%
Federated Hermes
33
Federated Hermes
Pennsylvania
$601K +$777K +236,532 New
ECM
34
Endurant Capital Management
California
$590K -$2.64M -802,342 -78%
PHP
35
Parkman Healthcare Partners
Connecticut
$572K -$574K -174,609 -44%
DCM
36
Dupont Capital Management
Delaware
$506K – – –
AC
37
Alexandria Capital
Virginia
$479K – – –
Walleye Capital
38
Walleye Capital
New York
$433K +$139K +42,416 +33%
Charles Schwab
39
Charles Schwab
California
$423K -$1.35K -411 -0.2%
LCS
40
Levin Capital Strategies
New York
$413K +$69K +21,000 +15%
QI
41
QS Investors
New York
$410K – – –
SEI Investments
42
SEI Investments
Pennsylvania
$408K +$82.9K +25,226 +18%
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$390K +$504K +153,407 New
UBS Group
44
UBS Group
Switzerland
$389K +$151K +45,959 +43%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$344K – – –
Swiss National Bank
46
Swiss National Bank
Switzerland
$343K +$21.7K +6,600 +5%
IP
47
Intellectus Partners
California
$326K -$98K -29,840 -19%
Wells Fargo
48
Wells Fargo
California
$325K +$29.7K +9,043 +8%
Barclays
49
Barclays
United Kingdom
$319K +$186K +56,572 +82%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$271K +$4.04K +1,231 +1%
1
2
3 4 5

LAB Hedge Fund Activity: Q1 2020 in Review

103 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2020, worth a combined $163M — down 27% from $223M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new LAB positions and 12 closed out — a net gain of 7 holders — while 42 added to existing stakes and 32 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $4.64M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $3.9M sold.

  • 103 institutional investors held Standard BioTools (LAB) as of Q1 2020, up from 99 in Q4 2019.
  • Funds reported $163M of Standard BioTools stock for Q1 2020, down 27% quarter-over-quarter.
  • 19 funds opened new Standard BioTools positions in Q1 2020 and 12 closed out, a net change of +7 holders.
  • The largest Standard BioTools buyer in Q1 2020 was Russell Investments Group, an estimated $4.64M added.
  • The largest Standard BioTools seller in Q1 2020 was Alyeska Investment Group, an estimated $3.9M sold.

Based on aggregated 13F filings for Q1 2020.